Skip to main content
. 2021 Apr 27;16(4):e0250328. doi: 10.1371/journal.pone.0250328

Table 4. Factors associated with abnormal lipid levels among HIV-infected patients receiving ART in North Shewa, Ethiopia.

Variables TC ≥ 200 mg/dl TG ≥ 150 mg/dl HDL-c < 40 mg/dl LDL-c ≥ 130 mg/dl
Adjusted OR (95% CI) Adjusted OR (95% CI) Adjusted OR (95% CI) Adjusted OR (95% CI)
Age (years)
    ≤ 40 1 1 1
    > 40 2.51 (1.64–3.84) 2.95 (1.85–4.71) 2.02 (1.17–3.50) 3.37 (2.08–5.47)
    P-value 0.001 0.001 0.012 0.001
Sex
    Male NA 1.22 (0.75–1.98) 1.68 (0.97–2.94) NA
    Female NA 1 1 NA
    P-value 0.428 0.067
Residence
    Rural 1 NA 1 1
    Urban 1.48 (0.86–2.52) NA 2.61 (1.16–6.14) 1.81 (0.95–3.44)
    P-value 0.154 0.021 0.070
Education
    < High school NA 1 NA NA
    ≥ High school NA 1.32 (0.81–2.16) NA NA
    P-value 0.272
Duration of infection (years)
    < 5 1 1 1 1
    ≥ 5 1.12 (0.56–2.24) 1.38 (0.61–3.18) 0.64 (0.18–2.25) 1.08 (0.45–2.57)
    P-value 0.743 0.441 0.277 0.869
Duration on ART (years)
    < 5 1 1 1 1
    ≥ 5 1.54 (0.99–2.38) 1.86 (1.13–3.07) 3.47 (1.75–6.80) 2.20 (1.30–3.71)
    P-value 0.050 0.015 0.020 0.003
Smoking
    No 1 1 1 1
    Yes 1.83 (0.59–5.68) 2.85 (0.77–10.52) 3.61 (1.06–12.34) 1.81 (0.93–3.36)
P-value 0.292 0.117 0.040 0.383
Alcohol use
    No 1 1 NA NA
    Yes 0.51 (0.24–1.08) 0.89 (0.38–2.13) NA NA
    P-value 0.078 0.808
Body mass index (Kg/m2),
    ≤ 25 1 1 1 1
    > 25 2.43 (1.19–4.97) 4.17 (2.01–8.67) 2.04 (0.92–4.52) 6.53 (3.05–13.98)
    P-value 0.015 0.001 0.078 0.001
CD4 count (cell/mm3)
    > 200 1 1 1 NA
    ≤ 200 1.65 (1.05–2.58) 0.81 (0.86–11.84) 0.58 (0.31–1.09) NA
    P-value 0.031 0.379 0.090

TC, total cholesterol; TG, triglyceride; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; ART, antiretroviral therapy; NA, not available.